{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:14:15Z","timestamp":1794244455230,"version":"4.9.0"},"reference-count":142,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The development of substance use disorders (SUDs) is partly determined by genetic factors. Brain-derived neurotrophic factor (BDNF) underlies the neurobiological mechanisms of action of psychoactive substances (PASs) and development of SUDs, while genetic markers within the BDNF gene may be associated with a risk of SUDs and accompanied clinical manifestations. This is a systematic review of the relationships between single nucleotide polymorphisms (SNPs) within the\n                    <jats:italic>BDNF<\/jats:italic>\n                    gene locus and various aspects of SUDs. We searched, appraised, and summarized the research evidence of these associations for the main pharmacological groups of PASs (tobacco, cannabis, alcohol, opioids, and stimulants). Most studies have focused on the functional Val66Met (rs6265) polymorphism. They demonstrated that the rs6265 Met (T)\u00a0allele may be a protective factor for the development of SUDs. In addition to rs6265, other individual\n                    <jats:italic>BDNF<\/jats:italic>\n                    -related SNPs and the corresponding haplotypes were associated with the risk of the development of SUDs, their clinical manifestations, presence of comorbidity, and sensitivity to pharmacotherapy. The identified associations often depended on the studied population and were influenced by sex and ancestry. Established\n                    <jats:italic>BDNF<\/jats:italic>\n                    -related genetic markers or their combinations potentially may be used as objective diagnostic or prognostic criteria in clinical practice.\n                  <\/jats:p>","DOI":"10.1515\/revneuro-2025-0112","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:34:34Z","timestamp":1762306474000},"page":"141-188","source":"Crossref","is-referenced-by-count":5,"title":["<i>BDNF<\/i>\n                    gene polymorphisms and substance use disorders: a systematic review"],"prefix":"10.1515","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-9640","authenticated-orcid":false,"given":"Danil","family":"Peregud","sequence":"first","affiliation":[{"name":"Federal State Budgetary Institution \u201cV. Serbsky National Medical Research Centre for Psychiatry and Narcology\u201d of the Ministry of Health of the Russian Federation , Kropotkinsky ln. 23 , Moscow 119034 , Russia"},{"name":"Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences , Butlerova st. 5A , Moscow 117485 , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9715-4473","authenticated-orcid":false,"given":"Valeria","family":"Baronets","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u201cV. Serbsky National Medical Research Centre for Psychiatry and Narcology\u201d of the Ministry of Health of the Russian Federation , Kropotkinsky ln. 23 , Moscow 119034 , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-4952","authenticated-orcid":false,"given":"Olga","family":"Pavlova","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u201cV. Serbsky National Medical Research Centre for Psychiatry and Narcology\u201d of the Ministry of Health of the Russian Federation , Kropotkinsky ln. 23 , Moscow 119034 , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-7000","authenticated-orcid":false,"given":"Konstantin","family":"Pavlov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u201cV. Serbsky National Medical Research Centre for Psychiatry and Narcology\u201d of the Ministry of Health of the Russian Federation , Kropotkinsky ln. 23 , Moscow 119034 , Russia"},{"name":"Mental-Health Clinic No. 1 Named after N.A. Alekseev , Zagorodnoe Highway 2 , Moscow 115191 , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2026050312091653804_j_revneuro-2025-0112_ref_001","doi-asserted-by":"crossref","unstructured":"Agrawal, A., Lynskey, M.T., Kapoor, M., Bucholz, K.K., Edenberg, H.J., Schuckit, M., Brooks, A., Hesselbrock, V., Kramer, J., Saccone, N., et al. (2015). Are genetic variants for tobacco smoking associated with cannabis involvement? Drug Alcohol Depend. 150: 183\u2013187, https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.02.029.","DOI":"10.1016\/j.drugalcdep.2015.02.029"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_002","doi-asserted-by":"crossref","unstructured":"Al-Eitan, L.N., Jaradat, S.A., Hulse, G.K., and Tay, G.K. (2012). Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5: 497, https:\/\/doi.org\/10.1186\/1756-0500-5-497.","DOI":"10.1186\/1756-0500-5-497"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_003","doi-asserted-by":"crossref","unstructured":"Anmella, G., Vilches, S., Espadaler-Mazo, J., Murru, A., Pacchiarotti, I., Tuson, M., Garriga, M., Sol\u00e9, E., Brat, M., Fico, G., et al. (2021). Genetic variations associated with long-term treatment response in bipolar depression. Genes (Basel) 12: 1259, https:\/\/doi.org\/10.3390\/genes12081259.","DOI":"10.3390\/genes12081259"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_004","doi-asserted-by":"crossref","unstructured":"Autry, A.E. and Monteggia, L.M. (2012). Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64: 238\u2013258, https:\/\/doi.org\/10.1124\/pr.111.005108.","DOI":"10.1124\/pr.111.005108"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_005","doi-asserted-by":"crossref","unstructured":"Baj, G., Carlino, D., Gardossi, L., and Tongiorgi, E. (2013). Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking. Front. Neurosci. 7: 188, https:\/\/doi.org\/10.3389\/fnins.2013.00188.","DOI":"10.3389\/fnins.2013.00188"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_006","doi-asserted-by":"crossref","unstructured":"Bardeen, J.R., Daniel, T.A., Gratz, K.L., Vallender, E.J., Garrett, M.R., and Tull, M.T. (2020). The BDNF Val66Met polymorphism moderates the relationship between posttraumatic stress disorder and trauma script-evoked attentional bias to cocaine cues among patients with cocaine dependence. J.\u00a0Anxiety Disord. 72: 102223, https:\/\/doi.org\/10.1016\/j.janxdis.2020.102223.","DOI":"10.1016\/j.janxdis.2020.102223"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_007","doi-asserted-by":"crossref","unstructured":"Batalla, A., Lorenzetti, V., Chye, Y., Y\u00fccel, M., Soriano-Mas, C., Bhattacharyya, S., Torrens, M., Crippa, J.A.S., and Mart\u00edn-Santos, R. (2018). The influence of DAT1, COMT, and BDNF genetic polymorphisms on total and subregional hippocampal volumes in early onset heavy cannabis users. Cannabis Cannabinoid Res. 3: 1\u201310, https:\/\/doi.org\/10.1089\/can.2017.0021.","DOI":"10.1089\/can.2017.0021"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_008","doi-asserted-by":"crossref","unstructured":"Bawor, M., Dennis, B.B., Tan, C., Pare, G., Varenbut, M., Daiter, J., Plater, C., Worster, A., Marsh, D.C., Steiner, M., et al. (2015). Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study. Addict. Sci. Clin. Pract. 10: 19, https:\/\/doi.org\/10.1186\/s13722-015-0040-7.","DOI":"10.1186\/s13722-015-0040-7"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_009","doi-asserted-by":"crossref","unstructured":"Berent, D., Szyma\u0144ska, B., Kulczycka-Wojdala, D., Macander, M., Paw\u0142owska, Z., and Wojnar, M. (2020). The role of childhood adversities, FKBP5, BDNF, NRN1, and generalized self-efficacy in suicide attempts in alcohol-dependent patients. Pharmacol. Rep. 72: 730\u2013743, https:\/\/doi.org\/10.1007\/s43440-020-00080-8.","DOI":"10.1007\/s43440-020-00080-8"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_010","doi-asserted-by":"crossref","unstructured":"Beuten, J., Ma, J.Z., Payne, T.J., Dupont, R.T., Quezada, P., Huang, W., Crews, K.M., and Li, M.D. (2005). Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am. J.\u00a0Med. Genet. B Neuropsychiatr. Genet. 139B: 73\u201380, https:\/\/doi.org\/10.1002\/ajmg.b.30231.","DOI":"10.1002\/ajmg.b.30231"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_011","doi-asserted-by":"crossref","unstructured":"Biskupska, J., Borowiak, K.S., Karlin-Grazewicz, K., Janus, T., Waloszczyk, P., Potocka-Banas, B., Machoy-Mokrzynska, A., Ossowski, A., and Ciechanowicz, A. (2013). Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates. Hum. Exp. Toxicol. 32: 236\u2013240, https:\/\/doi.org\/10.1177\/0960327112459203.","DOI":"10.1177\/0960327112459203"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_012","doi-asserted-by":"crossref","unstructured":"Boro\u0144, A., Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Masiak, J., Trybek, G., Stro\u0144ska-Pluta, A., Rychel, M., and Grzywacz, A. (2024). Analysis of the BDNF gene rs6265 polymorphism in a group of women with alcohol use disorder, taking into account personality traits. Int. J.\u00a0Mol. Sci. 25: 6448, https:\/\/doi.org\/10.3390\/ijms25126448.","DOI":"10.3390\/ijms25126448"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_013","doi-asserted-by":"crossref","unstructured":"Bousman, C.A. and Dunlop, B.W. (2018). Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools. Pharmacogenomics J. 18: 613\u2013622, https:\/\/doi.org\/10.1038\/s41397-018-0027-3.","DOI":"10.1038\/s41397-018-0027-3"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_014","doi-asserted-by":"crossref","unstructured":"Bousman, C.A., Glatt, S.J., Cherner, M., Atkinson, J.H., Grant, I., Tsuang, M.T., Everall, I.P., and HNRC, Group. (2010). Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res. 178: 295\u2013298, https:\/\/doi.org\/10.1016\/j.psychres.2009.07.019.","DOI":"10.1016\/j.psychres.2009.07.019"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_015","doi-asserted-by":"crossref","unstructured":"Caffino, L., Mottarlini, F., Bilel, S., Targa, G., Tirri, M., Maggi, C., Marti, M., and Fumagalli, F. (2021). Single exposure to the cathinones MDPV and \u03b1-PVP alters molecular markers of neuroplasticity in the adult mouse brain. Int. J.\u00a0Mol. Sci. 22: 7397, https:\/\/doi.org\/10.3390\/ijms22147397.","DOI":"10.3390\/ijms22147397"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_016","doi-asserted-by":"crossref","unstructured":"Carver, C.S., LeMoult, J., Johnson, S.L., and Joormann, J. (2014). Gene effects and G \u00d7 E interactions in the differential prediction of three aspects of impulsiveness. Soc. Psychol. Personal. Sci. 5: 730\u2013739, https:\/\/doi.org\/10.1177\/1948550614527116.","DOI":"10.1177\/1948550614527116"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_017","doi-asserted-by":"crossref","unstructured":"Castillo-Carniglia, A., Keyes, K.M., Hasin, D.S., and Cerd\u00e1, M. (2019). Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry 6: 1068\u20131080, https:\/\/doi.org\/10.1016\/s2215-0366(19)30222-6.","DOI":"10.1016\/S2215-0366(19)30222-6"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_018","doi-asserted-by":"crossref","unstructured":"Cheah, S.Y., Lawford, B.R., Young, R.M., Connor, J.P., Phillip Morris, C., and Voisey, J. (2014). BDNF SNPs are implicated in comorbid alcohol dependence in schizophrenia but not in alcohol-dependent patients without schizophrenia. Alcohol Alcohol 49: 491\u2013497, https:\/\/doi.org\/10.1093\/alcalc\/agu040.","DOI":"10.1093\/alcalc\/agu040"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_019","doi-asserted-by":"crossref","unstructured":"Chen, S.L., Lee, S.Y., Chang, Y.H., Wang, T.Y., Chen, S.H., Chu, C.H., Chen, P.S., Yang, Y.K., Hong, J.S., and Lu, R.B. (2015). The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese heroin-dependent patients. Sci. Rep. 5: 8148, https:\/\/doi.org\/10.1038\/srep08148.","DOI":"10.1038\/srep08148"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_020","doi-asserted-by":"crossref","unstructured":"Chen, S., Zhou, W., and Lai, M. (2024). Synthetic cathinones: epidemiology, toxicity, potential for abuse, and current public health perspective. Brain Sci. 14: 334, https:\/\/doi.org\/10.3390\/brainsci14040334.","DOI":"10.3390\/brainsci14040334"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_021","doi-asserted-by":"crossref","unstructured":"Cheng, C.Y., Hong, C.J., Yu, Y.W., Chen, T.J., Wu, H.C., and Tsai, S.J. (2005). Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res. Mol. Brain Res. 140: 86\u201390, https:\/\/doi.org\/10.1016\/j.molbrainres.2005.07.008.","DOI":"10.1016\/j.molbrainres.2005.07.008"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_022","doi-asserted-by":"crossref","unstructured":"Crist, R.C., Reiner, B.C., and Berrettini, W.H. (2019). A review of opioid addiction genetics. Curr. Opin. Psychol. 27: 31\u201335, https:\/\/doi.org\/10.1016\/j.copsyc.2018.07.014.","DOI":"10.1016\/j.copsyc.2018.07.014"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_023","doi-asserted-by":"crossref","unstructured":"Cuy\u00e0s, E., Verdejo-Garc\u00eda, A., Fagundo, A.B., Khymenets, O., Rodr\u00edguez, J., Cuenca, A., de Sola Llopis, S., Langohr, K., Pe\u00f1a-Casanova, J., Torrens, M., et al. (2011). The influence of genetic and environmental factors among MDMA users in cognitive performance. PLoS One 6: e27206, https:\/\/doi.org\/10.1371\/journal.pone.0027206.","DOI":"10.1371\/journal.pone.0027206"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_024","doi-asserted-by":"crossref","unstructured":"Dalvie, S., Stein, D.J., Koenen, K., Cardenas, V., Cuzen, N.L., Ramesar, R., Fein, G., and Brooks, S.J. (2014). The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry 14: 328, https:\/\/doi.org\/10.1186\/s12888-014-0328-2.","DOI":"10.1186\/s12888-014-0328-2"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_025","doi-asserted-by":"crossref","unstructured":"de Cid, R., Fonseca, F., Gratac\u00f2s, M., Gutierrez, F., Mart\u00edn-Santos, R., Estivill, X., and Torrens, M. (2008). BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Gene Brain Behav. 7: 515\u2013522, https:\/\/doi.org\/10.1111\/j.1601-183X.2007.00386.x.","DOI":"10.1111\/j.1601-183X.2007.00386.x"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_026","doi-asserted-by":"crossref","unstructured":"Deak, J.D. and Johnson, E.C. (2021). Genetics of substance use disorders: a review. Psychol. Med. 51: 2189\u20132200, https:\/\/doi.org\/10.1017\/s0033291721000969.","DOI":"10.1017\/S0033291721000969"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_027","doi-asserted-by":"crossref","unstructured":"Decoster, J., van Os, J., Kenis, G., Henquet, C., Peuskens, J., De Hert, M., and van Winkel, R. (2011). Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. Am. J.\u00a0Med. Genet. B Neuropsychiatr. Genet. 156B: 363\u2013369, https:\/\/doi.org\/10.1002\/ajmg.b.31174.","DOI":"10.1002\/ajmg.b.31174"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_028","doi-asserted-by":"crossref","unstructured":"Devlin, P., Cao, X., and Stanfill, A.G. (2021). Genotype-expression interactions for BDNF across human brain regions. BMC Genomics 22: 207, https:\/\/doi.org\/10.1186\/s12864-021-07525-1.","DOI":"10.1186\/s12864-021-07525-1"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_029","doi-asserted-by":"crossref","unstructured":"Duart-Castells, L., L\u00f3pez-Arnau, R., Vizca\u00edno, S., Camarasa, J., Pubill, D., and Escubedo, E. (2019). 7,8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: differential role of the BDNF-TrkB pathway. Biochem. Pharmacol. 163: 84\u201393, https:\/\/doi.org\/10.1016\/j.bcp.2019.02.004.","DOI":"10.1016\/j.bcp.2019.02.004"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_030","doi-asserted-by":"crossref","unstructured":"Durazzo, T.C., Hutchison, K.E., Fryer, S.L., Mon, A., and Meyerhoff, D.J. (2012). Associations of cigarette smoking and polymorphisms in brain-derived neurotrophic factor and Catechol-O-Methyltransferase with neurocognition in alcohol dependent individuals during early abstinence. Front. Pharmacol. 3: 178, https:\/\/doi.org\/10.3389\/fphar.2012.00178.","DOI":"10.3389\/fphar.2012.00178"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_031","doi-asserted-by":"crossref","unstructured":"Durazzo, T.C., McNerney, M.W., Hansen, A.M., Gu, M., Sacchet, M.D., and Padula, C.B. (2023). BDNF rs6265 Met carriers with alcohol use disorder show greater age-related decline of N-acetylaspartate in left dorsolateral prefrontal cortex. Drug Alcohol Depend. 248: 109901, https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109901.","DOI":"10.1016\/j.drugalcdep.2023.109901"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_032","doi-asserted-by":"crossref","unstructured":"Espadaler, J., Tuson, M., Lopez-Ibor, J.M., Lopez-Ibor, F., and Lopez-Ibor, M.I. (2017). Pharmacogenetic testing for the guidance of psychiatric treatment: a multicenter retrospective analysis. CNS Spectr. 22: 315\u2013324, https:\/\/doi.org\/10.1017\/s1092852915000711.","DOI":"10.1017\/S1092852915000711"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_033","doi-asserted-by":"crossref","unstructured":"Evangelia, L., Ilias, K., Leonidas, M., Elias, T., and Maria, G. (2024). Deciphering the role of genetics in alcohol use disorder. In: Martin, C.R., Preedy, V.R., Patel, V.B., and Rajendram, R. (Eds.). Handbook of the biology and pathology of mental disorders. Springer, Cham, pp.\u00a01\u201334.","DOI":"10.1007\/978-3-031-32035-4_119-1"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_034","doi-asserted-by":"crossref","unstructured":"Evangelou, E., Gao, H., Chu, C., Ntritsos, G., Blakeley, P., Butts, A.R., Pazoki, R., Suzuki, H., Koskeridis, F., Yiorkas, A.M., et al. (2019). New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders. Nat. Hum. Behav. 3: 950\u2013961, https:\/\/doi.org\/10.1038\/s41562-019-0653-z.","DOI":"10.1038\/s41562-019-0653-z"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_035","doi-asserted-by":"crossref","unstructured":"Fan, Y., Luan, X., Wang, X., Li, H., Zhao, H., Li, S., Li, X., and Qiu, Z. (2025). Exploring the association between BDNF related signaling pathways and depression: a literature review. Brain Res. Bull. 220: 111143, https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111143.","DOI":"10.1016\/j.brainresbull.2024.111143"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_036","doi-asserted-by":"crossref","unstructured":"Feltenstein, M.W. and See, R.E. (2013). Systems level neuroplasticity in drug addiction. Cold Spring. Harb. Perspect. Med. 3: a011916, https:\/\/doi.org\/10.1101\/cshperspect.a011916.","DOI":"10.1101\/cshperspect.a011916"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_037","doi-asserted-by":"crossref","unstructured":"Forero, D.A., L\u00f3pez-Le\u00f3n, S., Shin, H.D., Park, B.L., and Kim, D.J. (2015). Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence. Drug Alcohol Depend 149: 259\u2013263, https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.01.017.","DOI":"10.1016\/j.drugalcdep.2015.01.017"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_038","doi-asserted-by":"crossref","unstructured":"Gao, X., Wang, Y., Lang, M., Yuan, L., Reece, A.S., and Wang, W. (2017). Contribution of genetic polymorphisms and haplotypes in DRD2, BDNF, and opioid receptors to heroin dependence and endophenotypes among the Han Chinese. OMICS 21: 404\u2013412, https:\/\/doi.org\/10.1089\/omi.2017.0057.","DOI":"10.1089\/omi.2017.0057"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_039","doi-asserted-by":"crossref","unstructured":"Gelernter, J. and Polimanti, R. (2021). Genetics of substance use disorders in the era of big data. Nat. Rev. Genet. 22: 712\u2013729, https:\/\/doi.org\/10.1038\/s41576-021-00377-1.","DOI":"10.1038\/s41576-021-00377-1"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_040","doi-asserted-by":"crossref","unstructured":"Gerring, Z.F., Thorp, J.G., Treur, J.L., Verweij, K.J.H., and Derks, E.M. (2024). The genetic landscape of substance use disorders. Mol. Psychiatr. 29: 3694\u20133705, https:\/\/doi.org\/10.1038\/s41380-024-02547-z.","DOI":"10.1038\/s41380-024-02547-z"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_041","doi-asserted-by":"crossref","unstructured":"Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., Pickering, R.P., and Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 61: 807\u2013816, https:\/\/doi.org\/10.1001\/archpsyc.61.8.807.","DOI":"10.1001\/archpsyc.61.8.807"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_042","doi-asserted-by":"crossref","unstructured":"Gratac\u00f2s, M., Gonz\u00e1lez, J.R., Mercader, J.M., de Cid, R., Urretavizcaya, M., and Estivill, X. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 61: 911\u2013922, https:\/\/doi.org\/10.1016\/j.biopsych.2006.08.025.","DOI":"10.1016\/j.biopsych.2006.08.025"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_043","doi-asserted-by":"crossref","unstructured":"Greenwald, M.K., Steinmiller, C.L., Sliwerska, E., Lundahl, L., and Burmeister, M. (2013). BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict. Biol. 18: 836\u2013845, https:\/\/doi.org\/10.1111\/j.1369-1600.2011.00431.x.","DOI":"10.1111\/j.1369-1600.2011.00431.x"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_044","doi-asserted-by":"crossref","unstructured":"Grzywacz, A., Samochowiec, A., Ciechanowicz, A., and Samochowiec, J. (2010). Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence. Pharmacol. Rep. 62: 938\u2013941, https:\/\/doi.org\/10.1016\/s1734-1140(10)70354-6.","DOI":"10.1016\/S1734-1140(10)70354-6"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_045","doi-asserted-by":"crossref","unstructured":"Guerin, A.A., Nestler, E.J., Berk, M., Lawrence, A.J., Rossell, S.L., and Kim, J.H. (2021). Genetics of methamphetamine use disorder: a systematic review and meta-analyses of gene association studies. Neurosci. Biobehav. Rev. 120: 48\u201374, https:\/\/doi.org\/10.1016\/j.neubiorev.2020.11.001.","DOI":"10.1016\/j.neubiorev.2020.11.001"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_046","doi-asserted-by":"crossref","unstructured":"Guerin, A.A., Spolding, B., Bozaoglu, K., Swinton, C., Liu, Z., Panizzutti Parry, B., Truong, T., Dean, B., Lawrence, A.J., Bonomo, Y., et al. (2024). Associations between methamphetamine use disorder and SLC18A1, SLC18A2, BDNF, and FAAH gene sequence variants and expression levels. Dialogues Clin. Neurosci. 26: 64\u201376, https:\/\/doi.org\/10.1080\/19585969.2024.2413476.","DOI":"10.1080\/19585969.2024.2413476"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_047","doi-asserted-by":"crossref","unstructured":"Haerian, B.S. (2013). BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis. Pharmacogenomics 14: 2055\u20132065, https:\/\/doi.org\/10.2217\/pgs.13.217.","DOI":"10.2217\/pgs.13.217"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_048","doi-asserted-by":"crossref","unstructured":"Hall, F.S., Drgonova, J., Jain, S., and Uhl, G.R. (2013). Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? Pharmacol. Ther. 140: 267\u2013279, https:\/\/doi.org\/10.1016\/j.pharmthera.2013.07.006.","DOI":"10.1016\/j.pharmthera.2013.07.006"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_049","doi-asserted-by":"crossref","unstructured":"Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F., and Weinberger, D.R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J.\u00a0Neurosci. 23: 6690\u20136694, https:\/\/doi.org\/10.1523\/jneurosci.23-17-06690.2003.","DOI":"10.1523\/JNEUROSCI.23-17-06690.2003"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_050","doi-asserted-by":"crossref","unstructured":"Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H.J., Lang, U.E., Fusar-Poli, P., and Borgwardt, S. (2015). BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 55: 107\u2013118, https:\/\/doi.org\/10.1016\/j.neubiorev.2015.04.017.","DOI":"10.1016\/j.neubiorev.2015.04.017"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_051","doi-asserted-by":"crossref","unstructured":"Hatoum, A.S., Colbert, S.M.C., Johnson, E.C., Huggett, S.B., Deak, J.D., Pathak, G., Jennings, M.V., Paul, S.E., Karcher, N.R., Hansen, I., et al. (2023). Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders. Nat. Ment. Health 1: 210\u2013223, https:\/\/doi.org\/10.1038\/s44220-023-00034-y.","DOI":"10.1101\/2022.01.06.22268753"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_052","doi-asserted-by":"crossref","unstructured":"He, L., Liao, Y., Wu, Q., and Liu, T. (2020). Association between brain-derived neurotrophic factor Val66Met polymorphism and methamphetamine use disorder: a meta-analysis. Front. Psychiatry 11: 585852, https:\/\/doi.org\/10.3389\/fpsyt.2020.585852.","DOI":"10.3389\/fpsyt.2020.585852"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_053","doi-asserted-by":"crossref","unstructured":"Heinzerling, K.G., McCracken, J.T., Swanson, A.N., Ray, L.A., and Shoptaw, S.J. (2012). COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation. J.\u00a0Clin. Psychopharmacol. 32: 135\u2013137, https:\/\/doi.org\/10.1097\/jcp.0b013e318240a48e.","DOI":"10.1097\/JCP.0b013e318240a48e"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_054","doi-asserted-by":"crossref","unstructured":"Heinzerling, K.G. and Shoptaw, S. (2012). Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use. Gend. Med. 9: 112\u2013120, https:\/\/doi.org\/10.1016\/j.genm.2012.02.005.","DOI":"10.1016\/j.genm.2012.02.005"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_055","doi-asserted-by":"crossref","unstructured":"Hoefer, M.E., Pennington, D.L., Durazzo, T.C., Mon, A., Ab\u00e9, C., Truran, D., Hutchison, K.E., and Meyerhoff, D.J. (2014). Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. Alcohol 48: 631\u2013638, https:\/\/doi.org\/10.1016\/j.alcohol.2014.08.007.","DOI":"10.1016\/j.alcohol.2014.08.007"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_056","doi-asserted-by":"crossref","unstructured":"Hou, H., Qing, Z., Jia, S., Zhang, X., Hu, S., and Hu, J. (2010). Influence of brain-derived neurotrophic factor (val66met) genetic polymorphism on the ages of onset for heroin abuse in males. Brain Res. 1353: 245\u2013248, https:\/\/doi.org\/10.1016\/j.brainres.2010.07.022.","DOI":"10.1016\/j.brainres.2010.07.022"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_057","doi-asserted-by":"crossref","unstructured":"Iamjan, S.A., Thanoi, S., Watiktinkorn, P., Nudmamud-Thanoi, S., and Reynolds, G.P. (2015). BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. Pharmacogenomics 16: 1541\u20131545, https:\/\/doi.org\/10.2217\/pgs.15.96.","DOI":"10.2217\/pgs.15.96"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_058","doi-asserted-by":"crossref","unstructured":"Itoh, K., Hashimoto, K., Shimizu, E., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Iwata, N., Komiyama, T., Yamada, M., et al. (2005). Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am. J.\u00a0Med. Genet. B Neuropsychiatr. Genet. 132B: 70\u201373, https:\/\/doi.org\/10.1002\/ajmg.b.30097.","DOI":"10.1002\/ajmg.b.30097"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_059","doi-asserted-by":"crossref","unstructured":"Jamal, M., Van der Does, W., and Penninx, B.W. (2015). Effect of variation in BDNF Val(66)Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders. Drug Alcohol Depend 148: 150\u2013157, https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.12.032.","DOI":"10.1016\/j.drugalcdep.2014.12.032"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_060","doi-asserted-by":"crossref","unstructured":"Jenwitheesuk, A., Pabalan, N., Tapanadechopone, P., Jarjanazi, H., Arunphalungsanti, K., and Tharabenjasin, P. (2025). Association of brain-derived neurotrophic factor polymorphisms with alcohol use disorder: an updated meta-analysis of genetic association studies. Brain Behav. 15: e70359, https:\/\/doi.org\/10.1002\/brb3.70359.","DOI":"10.1002\/brb3.70359"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_061","doi-asserted-by":"crossref","unstructured":"Jia, W., Shi, J.G., Wu, B., Ao, L., Zhang, R., and Zhu, Y.S. (2011). Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence. Neurosci. Lett. 495: 221\u2013224, https:\/\/doi.org\/10.1016\/j.neulet.2011.03.072.","DOI":"10.1016\/j.neulet.2011.03.072"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_062","doi-asserted-by":"crossref","unstructured":"Jin, T., Zhang, H., Yang, Q., Li, L., Ouyang, Y., Yang, M., Wang, F., Wang, Z., Zhang, J., and Yuan, D. (2016). The relationship between polymorphisms of BDNFOS and BDNF genes and heroin addiction in the Han Chinese population. J.\u00a0Gene Med. 18: 288\u2013293, https:\/\/doi.org\/10.1002\/jgm.2927.","DOI":"10.1002\/jgm.2927"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_063","doi-asserted-by":"crossref","unstructured":"Jones, S.C., Cardone, K.M., Bradford, Y., Tishkoff, S.A., and Ritchie, M.D. (2025). The impact of ancestry on genome-wide association studies. Pac. Symp. Biocomput. 30: 251\u2013267, https:\/\/doi.org\/10.1142\/9789819807024_0019.","DOI":"10.1142\/9789819807024_0019"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_064","doi-asserted-by":"crossref","unstructured":"Kalivas, P.W. and O\u2019Brien, C. (2008). Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33: 166\u2013180, https:\/\/doi.org\/10.1038\/sj.npp.1301564.","DOI":"10.1038\/sj.npp.1301564"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_065","doi-asserted-by":"crossref","unstructured":"Karlsson Linn\u00e9r, R., Biroli, P., Kong, E., Meddens, S.F.W., Wedow, R., Fontana, M.A., Lebreton, M., Tino, S.P., Abdellaoui, A., Hammerschlag, A.R., et al. (2019). Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat. Genet. 51: 245\u2013257, https:\/\/doi.org\/10.1038\/s41588-018-0309-3.","DOI":"10.1038\/s41588-018-0309-3"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_066","doi-asserted-by":"crossref","unstructured":"Kaya-Aky\u00fczl\u00fc, D., \u00d6zkan-Kotilo\u011flu, S., Bal, C., Avc\u0131o\u011flu, G., Yal\u00e7\u0131n-\u015eahiner, \u015e., and \u015eahiner, \u0130.V. (2022). Sublingual buprenorphine\/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder. Environ. Toxicol. Pharmacol. 95: 103979, https:\/\/doi.org\/10.1016\/j.etap.2022.103979.","DOI":"10.1016\/j.etap.2022.103979"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_067","doi-asserted-by":"crossref","unstructured":"Kilpatrick, D.G., Resnick, H.S., Milanak, M.E., Miller, M.W., Keyes, K.M., and Friedman, M.J. (2013). National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J.\u00a0Trauma Stress. 26: 537\u2013547, https:\/\/doi.org\/10.1002\/jts.21848.","DOI":"10.1002\/jts.21848"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_068","doi-asserted-by":"crossref","unstructured":"Klimkiewicz, A., Mach, A., Jakubczyk, A., Klimkiewicz, J., Wnorowska, A., Kopera, M., Fudalej, S., Burmeister, M., Brower, K., and Wojnar, M. (2017). COMT and BDNF gene variants help to predict alcohol consumption in alcohol-dependent patients. J.\u00a0Addict. Med. 11: 114\u2013118, https:\/\/doi.org\/10.1097\/adm.0000000000000277.","DOI":"10.1097\/ADM.0000000000000277"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_069","doi-asserted-by":"crossref","unstructured":"Koskela, M., B\u00e4ck, S., V\u00f5ikar, V., Richie, C.T., Domanskyi, A., Harvey, B.K., and Airavaara, M. (2017). Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol. Dis. 97: 189\u2013200, https:\/\/doi.org\/10.1016\/j.nbd.2016.05.010.","DOI":"10.1016\/j.nbd.2016.05.010"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_070","doi-asserted-by":"crossref","unstructured":"Kourosh-Arami, M., Komaki, A., and Gholami, M. (2022). Addiction-induced plasticity in underlying neural circuits. Neurol. Sci. 43: 1605\u20131615, https:\/\/doi.org\/10.1007\/s10072-021-05778-y.","DOI":"10.1007\/s10072-021-05778-y"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_071","doi-asserted-by":"crossref","unstructured":"Lacroix, A., Ramoz, N., Girard, M., Plansont, B., Poupon, D., Gorwood, P., and Nubukpo, P. (2023). BDNF CpG methylation and serum levels covary during alcohol withdrawal in patients with alcohol use disorder: a pilot study. World J.\u00a0Biol. Psychiatry 24: 854\u2013859, https:\/\/doi.org\/10.1080\/15622975.2023.2242924.","DOI":"10.1080\/15622975.2023.2242924"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_072","doi-asserted-by":"crossref","unstructured":"Levchenko, A., Malov, S., Antonik, A., Protsvetkina, A., Rybakova, K.V., Kanapin, A., Yakovlev, A.N., Nenasteva, A.Y., Nikolishin, A.E., Cherkasov, N., et al. (2022). A genome-wide association study reveals a BDNF-centered molecular network associated with alcohol dependence and related clinical measures. Biomedicines 10: 3007, https:\/\/doi.org\/10.3390\/biomedicines10123007.","DOI":"10.3390\/biomedicines10123007"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_073","doi-asserted-by":"crossref","unstructured":"Levran, O., Peles, E., Randesi, M., Shu, X., Ott, J., Shen, P.H., Adelson, M., and Kreek, M.J. (2013). Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics 14: 755\u2013768, https:\/\/doi.org\/10.2217\/pgs.13.58.","DOI":"10.2217\/pgs.13.58"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_074","doi-asserted-by":"crossref","unstructured":"Li, M.D., Ma, J.Z., Cheng, R., Dupont, R.T., Williams, N.J., Crews, K.M., Payne, T.J., Elston, R.C., and Study, Framingham Heart (2003). A genome-wide scan to identify loci for smoking rate in the Framingham heart study population. BMC Genet. 4: S103, https:\/\/doi.org\/10.1186\/1471-2156-4-s1-s103.","DOI":"10.1186\/1471-2156-4-S1-S103"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_075","doi-asserted-by":"crossref","unstructured":"Li, S., Weinstein, G., Zare, H., Teumer, A., V\u00f6lker, U., Friedrich, N., Knol, M.J., Satizabal, C.L., Petyuk, V.A., Adams, H.H.H., et al. (2020). The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages. Brain Commun. 2: fcaa176, https:\/\/doi.org\/10.1093\/braincomms\/fcaa176.","DOI":"10.1093\/braincomms\/fcaa176"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_076","doi-asserted-by":"crossref","unstructured":"Liu, M., Jiang, Y., Wedow, R., Li, Y., Brazel, D.M., Chen, F., Datta, G., Davila-Velderrain, J., McGuire, D., Tian, C., et al. (2019). Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat. Genet. 51: 237\u2013244, https:\/\/doi.org\/10.1038\/s41588-018-0307-5.","DOI":"10.1038\/s41588-018-0307-5"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_077","doi-asserted-by":"crossref","unstructured":"Liu, Q.R., Walther, D., Drgon, T., Polesskaya, O., Lesnick, T.G., Strain, K.J., de Andrade, M., Bower, J.H., Maraganore, D.M., and Uhl, G.R. (2005). Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson\u2019s disease. Am. J.\u00a0Med. Genet. B Neuropsychiatr. Genet. 134B: 93\u2013103, https:\/\/doi.org\/10.1002\/ajmg.b.30109.","DOI":"10.1002\/ajmg.b.30109"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_078","doi-asserted-by":"crossref","unstructured":"Lodhi, R.J., Wang, Y., Macintyre, G., Crocker, C., Loverock, A., Henriques, B.C., Heywood, B., Sivapalan, S., Bowker, A., Majeau, B., et al. (2019). Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis. Psychiatry Res. 280: 112500, https:\/\/doi.org\/10.1016\/j.psychres.2019.112500.","DOI":"10.1016\/j.psychres.2019.112500"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_079","doi-asserted-by":"crossref","unstructured":"Lopez-Leon, S., Gonz\u00e1lez-Giraldo, Y., Wegman-Ostrosky, T., and Forero, D.A. (2021). Molecular genetics of substance use disorders: an umbrella review. Neurosci. Biobehav. Rev. 124: 358\u2013369, https:\/\/doi.org\/10.1016\/j.neubiorev.2021.01.019.","DOI":"10.1016\/j.neubiorev.2021.01.019"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_080","doi-asserted-by":"crossref","unstructured":"Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D.I., and Yucel, M. (2014). The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature. Curr. Pharm. Des. 20: 2138\u20132167, https:\/\/doi.org\/10.2174\/13816128113199990435.","DOI":"10.2174\/13816128113199990435"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_081","doi-asserted-by":"crossref","unstructured":"Mancusi, G., Miuli, A., Santorelli, M., Cavallotto, C., Susini, O., Pernaci, G., V\u00fdborov\u00e1, E., Rosa, I., d\u2019Onofrio, A.M., Camardese, G., et al. (2024). Exploring peripheral biomarkers in psychostimulant use: a systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors. Behav. Brain Res. 469: 115046, https:\/\/doi.org\/10.1016\/j.bbr.2024.115046.","DOI":"10.1016\/j.bbr.2024.115046"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_082","doi-asserted-by":"crossref","unstructured":"Man\u00e9, A., Berg\u00e9, D., Penzol, M.J., Parellada, M., Bioque, M., Lobo, A., Gonz\u00e1lez-Pinto, A., Corripio, I., Cabrera, B., S\u00e1nchez-Torres, A.M., et al. (2017). Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Res. 250: 38\u201343, https:\/\/doi.org\/10.1016\/j.psychres.2017.01.045.","DOI":"10.1016\/j.psychres.2017.01.045"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_083","doi-asserted-by":"crossref","unstructured":"Matsushita, S., Kimura, M., Miyakawa, T., Yoshino, A., Murayama, M., Masaki, T., and Higuchi, S. (2004). Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin. Exp. Res. 28: 1609\u20131612, https:\/\/doi.org\/10.1097\/01.alc.0000145697.81741.d2.","DOI":"10.1097\/01.ALC.0000145697.81741.D2"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_084","doi-asserted-by":"crossref","unstructured":"Meng, C., Lan, J., Wang, Y., Song, M., Gao, X., Ran, L., Moira, S., and Wang, W. (2012). Influence of brain-derived neurotrophic factor genetic polymorphisms on the ages of onset for heroin dependence in a Chinese population. Genet. Test. Mol. Biomarkers 16: 1044\u20131050, https:\/\/doi.org\/10.1089\/gtmb.2012.0016.","DOI":"10.1089\/gtmb.2012.0016"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_085","doi-asserted-by":"crossref","unstructured":"Miller, A.P., Bogdan, R., Agrawal, A., and Hatoum, A.S. (2024). Generalized genetic liability to substance use disorders. J.\u00a0Clin. Invest. 134: e172881, https:\/\/doi.org\/10.1172\/jci172881.","DOI":"10.1172\/JCI172881"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_086","doi-asserted-by":"crossref","unstructured":"Mo, M., Fu, X.Y., Zhang, X.L., Zhang, S.C., Zhang, H.Q., Wu, L., Li, J.L., and Zhou, L. (2021). Association of plasma pro-brain-derived neurotrophic factor (proBDNF)\/Mature brain-derived neurotrophic factor (mBDNF) levels with BDNF gene Val66Met polymorphism in alcohol dependence. Med. Sci. Monit. 27: e930421, https:\/\/doi.org\/10.12659\/msm.930421.","DOI":"10.12659\/MSM.930421"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_087","doi-asserted-by":"crossref","unstructured":"Mon, A., Durazzo, T.C., Gazdzinski, S., Hutchison, K.E., Pennington, D., and Meyerhoff, D.J. (2013). Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals. Gene Brain Behav. 12: 98\u2013107, https:\/\/doi.org\/10.1111\/j.1601-183x.2012.00854.x.","DOI":"10.1111\/j.1601-183X.2012.00854.x"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_088","doi-asserted-by":"crossref","unstructured":"Montag, C., Basten, U., Stelzel, C., Fiebach, C.J., and Reuter, M. (2008). The BDNF Val66Met polymorphism and smoking. Neurosci. Lett. 442: 30\u201333, https:\/\/doi.org\/10.1016\/j.neulet.2008.06.064.","DOI":"10.1016\/j.neulet.2008.06.064"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_089","doi-asserted-by":"crossref","unstructured":"Morelos-Santana, E., Islas-Preciado, D., Alcal\u00e1-Lozano, R., Gonz\u00e1lez-Olvera, J., and Estrada-Camarena, E. (2024). Peripheral neurotrophin levels during controlled crack\/cocaine abstinence: a systematic review and meta-analysis. Sci. Rep. 14: 1410, https:\/\/doi.org\/10.1038\/s41598-024-51901-2.","DOI":"10.1038\/s41598-024-51901-2"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_090","doi-asserted-by":"crossref","unstructured":"Muschler, M.A., Heberlein, A., Frieling, H., Vogel, N., Becker, C.M., Kornhuber, J., Bleich, S., and Hillemacher, T. (2011). Brain-derived neurotrophic factor, Val66Met single nucleotide polymorphism is not associated with alcohol dependence. Psychiatr. Genet. 21: 53\u201354, https:\/\/doi.org\/10.1097\/ypg.0b013e32834133ab.","DOI":"10.1097\/YPG.0b013e32834133ab"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_091","doi-asserted-by":"crossref","unstructured":"Nedic, G., Perkovic, M.N., Sviglin, K.N., Muck-Seler, D., Borovecki, F., and Pivac, N. (2013). Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes. Prog. Neuropsychopharmacol. Biol. Psychiatry 40: 193\u2013198, https:\/\/doi.org\/10.1016\/j.pnpbp.2012.09.005.","DOI":"10.1016\/j.pnpbp.2012.09.005"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_092","doi-asserted-by":"crossref","unstructured":"Neves, F.S., Malloy-Diniz, L., Romano-Silva, M.A., Campos, S.B., Miranda, D.M., De Marco, L., Figueira, P.G., Krebs, M.O., and Correa, H. (2011). The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J.\u00a0Affect. Disord. 131: 307\u2013311, https:\/\/doi.org\/10.1016\/j.jad.2010.11.022.","DOI":"10.1016\/j.jad.2010.11.022"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_093","doi-asserted-by":"crossref","unstructured":"Nguyen, V.T., Hill, B., Sims, N., Heck, A., Negron, M., Lusk, C., and Galindo, C.L. (2023). Brain-derived neurotrophic factor rs6265 (Val66Met) single nucleotide polymorphism as a master modifier of human pathophysiology. Neural Regen. Res. 18: 102\u2013106, https:\/\/doi.org\/10.4103\/1673-5374.343894.","DOI":"10.4103\/1673-5374.343894"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_094","doi-asserted-by":"crossref","unstructured":"Nubukpo, P., Ramoz, N., Girard, M., Malauzat, D., and Gorwood, P. (2017). Determinants of blood brain-derived neurotrophic factor blood levels in patients with alcohol use disorder. Alcohol Clin. Exp. Res. 41: 1280\u20131287, https:\/\/doi.org\/10.1111\/acer.13414.","DOI":"10.1111\/acer.13414"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_095","doi-asserted-by":"crossref","unstructured":"Ohmoto, M. and Takahashi, T. (2019). Effect of genetic polymorphism of brain-derived neurotrophic factor and serotonin transporter on smoking phenotypes: a pilot study of Japanese participants. Heliyon 5: e01234, https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01234.","DOI":"10.1016\/j.heliyon.2019.e01234"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_096","doi-asserted-by":"crossref","unstructured":"Ornell, F., Hansen, F., Schuch, F.B., Pezzini Rebelatto, F., Tavares, A.L., Scherer, J.N., Valerio, A.G., Pechansky, F., Paim Kessler, F.H., and von, Diemen L. (2018). Brain-derived neurotrophic factor in substance use disorders: a systematic review and meta-analysis. Drug Alcohol Depend 193: 91\u2013103, https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.036.","DOI":"10.1016\/j.drugalcdep.2018.08.036"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_097","doi-asserted-by":"crossref","unstructured":"Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., Brennan, S.E., et al. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372: n71, https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_098","doi-asserted-by":"crossref","unstructured":"Palma-\u00c1lvarez, R.F., Ros-Cucurull, E., Amaro-Hosey, K., Rodriguez-Cintas, L., Grau-L\u00f3pez, L., Corominas-Roso, M., S\u00e1nchez-Mora, C., and Roncero, C. (2017). Peripheral levels of BDNF and opiate-use disorder: literature review and update. Rev. Neurosci. 28: 499\u2013508, https:\/\/doi.org\/10.1515\/revneuro-2016-0078.","DOI":"10.1515\/revneuro-2016-0078"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_099","doi-asserted-by":"crossref","unstructured":"Panday, S.K., Shankar, V., Lyman, R.A., and Alexov, E. (2024). Genetic variants linked to opioid addiction: a genome-wide association study. Int. J.\u00a0Mol. Sci. 25: 12516, https:\/\/doi.org\/10.3390\/ijms252312516.","DOI":"10.3390\/ijms252312516"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_100","doi-asserted-by":"crossref","unstructured":"Peng, Q., Wilhelmsen, K.C., and Ehlers, C.L. (2021). Common genetic substrates of alcohol and substance use disorder severity revealed by pleiotropy detection against GWAS catalog in two populations. Addict. Biol. 26: e12877, https:\/\/doi.org\/10.1111\/adb.12877.","DOI":"10.1111\/adb.12877"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_101","doi-asserted-by":"crossref","unstructured":"Peregud, D.I., Baronets, V.Y., Terebilina, N.N., and Gulyaeva, N.V. (2023). Role of BDNF in neuroplasticity associated with alcohol dependence. Biochemistry (Mosc) 88: 404\u2013416, https:\/\/doi.org\/10.31857\/s0320972523030090.","DOI":"10.1134\/S0006297923030094"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_102","doi-asserted-by":"crossref","unstructured":"Peregud, D., Korolkov, A., Baronets, V., Kozlov, K., Lobacheva, A., Arkus, M., Bairamova, S., Solovieva, M., Pavlova, O., Pavlov, K., et al. (2024). Genetic determinants of serum brain-derived neurotrophic factor (BDNF) after alcohol withdrawal. Discov. Med. 1: 148, https:\/\/doi.org\/10.1007\/s44337-024-00144-1.","DOI":"10.1007\/s44337-024-00144-1"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_103","doi-asserted-by":"crossref","unstructured":"Pezawas, L., Verchinski, B.A., Mattay, V.S., Callicott, J.H., Kolachana, B.S., Straub, R.E., Egan, M.F., Meyer-Lindenberg, A., and Weinberger, D.R. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J.\u00a0Neurosci. 24: 10099\u201310102, https:\/\/doi.org\/10.1523\/jneurosci.2680-04.2004.","DOI":"10.1523\/JNEUROSCI.2680-04.2004"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_104","doi-asserted-by":"crossref","unstructured":"Rovaris, D.L., Schuch, J.B., Grassi-Oliveira, R., Sanvicente-Vieira, B., da Silva, B.S., Walss-Bass, C., M\u00fcller, D., Stolf, A.R., von Diemen, L., Ceres\u00e9r, K.M.M., et al. (2017). Effects of crack cocaine addiction and stress-related genes on peripheral BDNF levels. J.\u00a0Psychiatr. Res. 90: 78\u201385, https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.011.","DOI":"10.1016\/j.jpsychires.2017.02.011"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_105","doi-asserted-by":"crossref","unstructured":"Rovi\u0161, D., \u010cerneli\u010d Bizjak, M., Vasiljev Marchesi, V., Petelin, A., Jenu\u0161, T., Vidic, S., Dreven\u0161ek, G., and Jenko Pra\u017enikar, Z. (2018). Increased risk-taking behaviour and brain-derived neurotrophic factor Val66Met polymorphism correlates to decreased serum brain-derived neurotrophic factor level in heroin users. Eur. Addict. Res. 24: 189\u2013200, https:\/\/doi.org\/10.1159\/000492582.","DOI":"10.1159\/000492582"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_106","doi-asserted-by":"crossref","unstructured":"Roy, N., Barry, R.J., Fernandez, F.E., Lim, C.K., Al-Dabbas, M.A., Karamacoska, D., Broyd, S.J., Solowij, N., Chiu, C.L., and Steiner, G.Z. (2020). Electrophysiological correlates of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism. Sci. Rep. 10: 17915, https:\/\/doi.org\/10.1038\/s41598-020-74780-9.","DOI":"10.1038\/s41598-020-74780-9"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_107","doi-asserted-by":"crossref","unstructured":"Russo, S.J., Mazei-Robison, M.S., Ables, J.L., and Nestler, E.J. (2009). Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56: 73\u201382, https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.059.","DOI":"10.1016\/j.neuropharm.2008.06.059"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_108","doi-asserted-by":"crossref","unstructured":"Saha, S., Lim, C.C., Degenhardt, L., Cannon, D.L., Bremner, M., Prentis, F., Lawrence, Z., Heffernan, E., Meurk, C., Reilly, J., et al. (2022). Comorbidity between mood and substance-related disorders: a systematic review and meta-analysis. Aust. N. Z. J.\u00a0Psychiatry 56: 757\u2013770, https:\/\/doi.org\/10.1177\/00048674211054740.","DOI":"10.1177\/00048674211054740"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_109","doi-asserted-by":"crossref","unstructured":"Saunders, G.R.B., Wang, X., Chen, F., Jang, S.K., Liu, M., Wang, C., Gao, S., Jiang, Y., Khunsriraksakul, C., Otto, J.M., et al. (2022). Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature 612: 720\u2013724, https:\/\/doi.org\/10.1038\/s41586-022-05477-4.","DOI":"10.1038\/s41586-022-05477-4"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_110","doi-asserted-by":"crossref","unstructured":"Ser\u00fd, O., S\u0165astn\u00fd, F., Zvolsk\u00fd, P., Hlinomazov\u00e1, Z., and Balcar, V.J. (2011). Association between Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) gene and a deficiency of colour vision in alcohol-dependent male patients. Neurosci. Lett. 499: 154\u2013157, https:\/\/doi.org\/10.1016\/j.neulet.2011.05.038.","DOI":"10.1016\/j.neulet.2011.05.038"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_111","doi-asserted-by":"crossref","unstructured":"Shafiee, A., Jafarabady, K., Rafiei, M.A., Beiky, M., Seighali, N., Golpayegani, G., Jalali, M., Soltani Abhari, F., Arabzadeh Bahri, R., Safari, O., et al. (2023). Effect of alcohol on brain-derived neurotrophic factor (BDNF) blood levels: a systematic review and meta-analysis. Sci. Rep. 13: 17554, https:\/\/doi.org\/10.1038\/s41598-023-44798-w.","DOI":"10.1038\/s41598-023-44798-w"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_112","doi-asserted-by":"crossref","unstructured":"Shafiee, A., Rafiei, M.A., Jafarabady, K., Eskandari, A., Abhari, F.S., Sattari, M.A., Amini, M.J., and Bakhtiyari, M. (2024). Effect of cannabis use on blood levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF): a systematic review and meta-analysis. Brain Behav. 14: e3340, https:\/\/doi.org\/10.1002\/brb3.3340.","DOI":"10.1002\/brb3.3340"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_113","doi-asserted-by":"crossref","unstructured":"Shin, S., Stewart, R., Ferri, C.P., Kim, J.M., Shin, I.S., Kim, S.W., Yang, S.J., and Yoon, J.S. (2010). An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR, and MTHFR genes in older Korean men. Int. J.\u00a0Geriatr. Psychiatry 25: 441\u2013448, https:\/\/doi.org\/10.1002\/gps.2358.","DOI":"10.1002\/gps.2358"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_114","doi-asserted-by":"crossref","unstructured":"Shkundin, A. and Halaris, A. (2023). Associations of BDNF\/BDNF-AS SNPs with depression, schizophrenia, and bipolar disorder. J.\u00a0Pers. Med. 13: 1395, https:\/\/doi.org\/10.3390\/jpm13091395.","DOI":"10.3390\/jpm13091395"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_115","doi-asserted-by":"crossref","unstructured":"Sim, M.S., Mohamed, Z., Hatim, A., Rajagopal, V.L., and Habil, M.,H. (2010). Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res. 1357: 91\u201396, https:\/\/doi.org\/10.1016\/j.brainres.2010.08.053.","DOI":"10.1016\/j.brainres.2010.08.053"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_116","doi-asserted-by":"crossref","unstructured":"Sohani, Z.N., Meyre, D., de Souza, R.J., Joseph, P.G., Gandhi, M., Dennis, B.B., Norman, G., and Anand, S.S. (2015). Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genet. 16: 50, https:\/\/doi.org\/10.1186\/s12863-015-0211-2.","DOI":"10.1186\/s12863-015-0211-2"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_117","doi-asserted-by":"crossref","unstructured":"Spencer, J.L., Waters, E.M., Milner, T.A., Lee, F.S., and McEwen, B.S. (2010). BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function. Proc. Natl. Acad. Sci. USA. 107: 4395\u20134400, https:\/\/doi.org\/10.1073\/pnas.0915105107.","DOI":"10.1073\/pnas.0915105107"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_118","doi-asserted-by":"crossref","unstructured":"Stro\u0144ska-Pluta, A., Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Boro\u0144, A., Masiak, J., Sipak-Szmigiel, O., Rec\u0142aw, R., and Grzywacz, A. (2024). The relationship between the brain-derived neurotrophic factor gene polymorphism (Val66Met) and substance use disorder and relapse. Int. J.\u00a0Mol. Sci. 25: 788, https:\/\/doi.org\/10.3390\/ijms25020788.","DOI":"10.3390\/ijms25020788"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_119","doi-asserted-by":"crossref","unstructured":"Su, H., Tao, J., Zhang, J., Xie, Y., Han, B., Lu, Y., Sun, H., Wei, Y., Wang, Y., Zhang, Y., et al. (2015a). The analysis of BDNF gene polymorphism haplotypes and impulsivity in methamphetamine abusers. Compr. Psychiatry 59: 62\u201367, https:\/\/doi.org\/10.1016\/j.comppsych.2015.02.017.","DOI":"10.1016\/j.comppsych.2015.02.017"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_120","doi-asserted-by":"crossref","unstructured":"Su, H., Tao, J., Zhang, J., Xie, Y., Sun, Y., Li, L., Xu, K., Han, B., Lu, Y., Sun, H., et al. (2014). An association between BDNF Val66Met polymorphism and impulsivity in methamphetamine abusers. Neurosci. Lett. 582: 16\u201320, https:\/\/doi.org\/10.1016\/j.neulet.2014.08.030.","DOI":"10.1016\/j.neulet.2014.08.030"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_121","doi-asserted-by":"crossref","unstructured":"Su, H., Tao, J., Zhang, J., Xie, Y., Wang, Y., Zhang, Y., Han, B., Lu, Y., Sun, H., Wei, Y., et al. (2015b). The effects of BDNF Val66Met gene polymorphism on serum BDNF and cognitive function in methamphetamine-dependent patients and normal controls: a case-control study. J.\u00a0Clin. Psychopharmacol. 35: 517\u2013524, https:\/\/doi.org\/10.1097\/jcp.0000000000000390.","DOI":"10.1097\/JCP.0000000000000390"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_122","doi-asserted-by":"crossref","unstructured":"Su, N., Zhang, L., Fei, F., Hu, H., Wang, K., Hui, H., Jiang, X.F., Li, X., Zhen, H.N., Li, J., et al. (2011). The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response. Brain Res. 1415: 119\u2013126, https:\/\/doi.org\/10.1016\/j.brainres.2011.08.005.","DOI":"10.1016\/j.brainres.2011.08.005"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_123","doi-asserted-by":"crossref","unstructured":"Tajbakhsh, A., Alimardani, M., Asghari, M., Abedini, S., Saghafi Khadem, S., Nesaei Bajestani, A., Alipoor, F., Alidoust, M., Savardashtaki, A., Hashemian, P., et al. (2021). Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case-control study. BMC Med. Genomics 14: 27, https:\/\/doi.org\/10.1186\/s12920-021-00873-7.","DOI":"10.1186\/s12920-021-00873-7"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_124","doi-asserted-by":"crossref","unstructured":"Toh, Y.L., Ng, T., Tan, M., Tan, A., and Chan, A. (2018). Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: a systematic review. Brain Behav. 8: e01009, https:\/\/doi.org\/10.1002\/brb3.1009.","DOI":"10.1002\/brb3.1009"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_125","doi-asserted-by":"crossref","unstructured":"Tsai, S.J., Liao, D.L., Yu, Y.W., Chen, T.J., Wu, H.C., Lin, C.H., Cheng, C.Y., and Hong, C.J. (2005). A study of the association of (Val66Met) polymorphism in the brain-derived neurotrophic factor gene with alcohol dependence and extreme violence in Chinese males. Neurosci. Lett. 381: 340\u2013343, https:\/\/doi.org\/10.1016\/j.neulet.2005.02.043.","DOI":"10.1016\/j.neulet.2005.02.043"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_126","doi-asserted-by":"crossref","unstructured":"Uhl, G.R., Liu, Q.R., Walther, D., Hess, J., and Naiman, D. (2001). Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494\u00a0single-nucleotide polymorphisms. Am. J.\u00a0Hum. Genet. 69: 1290\u20131300, https:\/\/doi.org\/10.1086\/324467.","DOI":"10.1086\/324467"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_127","doi-asserted-by":"crossref","unstructured":"Wall, T.L., Luczak, S.E., and Hiller-Sturmh\u00f6fel, S. (2016). Biology, genetics, and environment: underlying factors influencing alcohol metabolism. Alcohol Res. 38: 59\u201368.","DOI":"10.35946\/arcr.v38.1.08"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_128","doi-asserted-by":"crossref","unstructured":"Walters, R.K., Polimanti, R., Johnson, E.C., McClintick, J.N., Adams, M.J., Adkins, A.E., Aliev, F., Bacanu, S.A., Batzler, A., Bertelsen, S., et al. (2018). Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat. Neurosci. 21: 1656\u20131669, https:\/\/doi.org\/10.1038\/s41593-018-0275-1.","DOI":"10.1038\/s41593-018-0275-1"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_129","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, O., Li, N., Sha, Z., Zhao, Z., and Xu, J. (2023). Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis. Front. Psychiatry 14: 1143833, https:\/\/doi.org\/10.3389\/fpsyt.2023.1143833.","DOI":"10.3389\/fpsyt.2023.1143833"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_130","doi-asserted-by":"crossref","unstructured":"Wang, L., Nu\u00f1ez, Y.Z., Mart\u00ednez-Maga\u00f1a, J.J., Rivera-Hernandez, M., Mao, Z., Brennand, K.J., Montalvo-Ortiz, J.L., Kranzler, H.R., Gelernter, J., and Zhou, H. (2025). Whole-exome sequencing study of opioid dependence offers novel insights into the contributions of exome variants. Transl. Psychiatry 15: 380, https:\/\/doi.org\/10.1038\/s41398-025-03578-y.","DOI":"10.1038\/s41398-025-03578-y"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_131","doi-asserted-by":"crossref","unstructured":"Wei, S.M., Baller, E.B., Kohn, P.D., Kippenhan, J.S., Kolachana, B., Soldin, S.J., Rubinow, D.R., Schmidt, P.J., and Berman, K.F. (2018). Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study. Mol. Psychiatr. 23: 1066\u20131075, https:\/\/doi.org\/10.1038\/mp.2017.72.","DOI":"10.1038\/mp.2017.72"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_132","doi-asserted-by":"crossref","unstructured":"Wei, S.M. and Berman, K.F. (2019). Ovarian hormones, genes, and the brain: the case of estradiol and the brain-derived neurotrophic factor (BDNF) gene. Neuropsychopharmacology 44: 223\u2013224, https:\/\/doi.org\/10.1038\/s41386-018-0223-5.","DOI":"10.1038\/s41386-018-0223-5"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_133","doi-asserted-by":"crossref","unstructured":"Wojnar, M., Brower, K.J., Strobbe, S., Ilgen, M., Matsumoto, H., Nowosad, I., Sliwerska, E., and Burmeister, M. (2009). Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence. Alcohol Clin. Exp. Res. 33: 693\u2013702, https:\/\/doi.org\/10.1111\/j.1530-0277.2008.00886.x.","DOI":"10.1111\/j.1530-0277.2008.00886.x"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_134","doi-asserted-by":"crossref","unstructured":"Wootton, R.E., Richmond, R.C., Stuijfzand, B.G., Lawn, R.B., Sallis, H.M., Taylor, G.M.J., Hemani, G., Jones, H.J., Zammit, S., Davey Smith, G., et al. (2020). Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study. Psychol. Med. 50: 2435\u20132443, https:\/\/doi.org\/10.1017\/s0033291719002678.","DOI":"10.1017\/S0033291719002678"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_135","doi-asserted-by":"crossref","unstructured":"Xu, H., Toikumo, S., Crist, R.C., Glogowska, K., Jinwala, Z., Deak, J.D., Justice, A.C., Gelernter, J., Johnson, E.C., Kranzler, H.R., et al. (2023). Identifying genetic loci and phenomic associations of substance use traits: a multi-trait analysis of GWAS (MTAG) study. Addiction 118: 1942\u20131952, https:\/\/doi.org\/10.1111\/add.16229.","DOI":"10.1111\/add.16229"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_136","doi-asserted-by":"crossref","unstructured":"Yang, S., Wang, F., Sun, L., Liu, X., Li, S., Chen, Y., Chen, L., Pan, Z., Kang, Y., Chen, Y.H., et al. (2024). The effects of BDNF rs6265 and FGF21 rs11665896 polymorphisms on alcohol use disorder-related impulsivity in Han Chinese adults. Front. Psychiatry 15: 1339558, https:\/\/doi.org\/10.3389\/fpsyt.2024.1339558.","DOI":"10.3389\/fpsyt.2024.1339558"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_137","doi-asserted-by":"crossref","unstructured":"Zai, C.C., Manchia, M., Zai, G.C., Woo, J., Tiwari, A.K., de Luca, V., and Kennedy, J.L. (2018). Association study of BDNF and DRD3 genes with alcohol use disorder in schizophrenia. Neurosci. Lett. 671: 1\u20136, https:\/\/doi.org\/10.1016\/j.neulet.2018.01.033.","DOI":"10.1016\/j.neulet.2018.01.033"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_138","doi-asserted-by":"crossref","unstructured":"Zhang, X.Y., Chen, D.C., Tan, Y.L., Luo, X., Zuo, L., Lv, M.H., Shah, N.N., Zunta-Soares, G.B., and Soares, J.C. (2015). Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study. J.\u00a0Psychiatr. Res. 60: 49\u201355, https:\/\/doi.org\/10.1016\/j.jpsychires.2014.09.023.","DOI":"10.1016\/j.jpsychires.2014.09.023"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_139","doi-asserted-by":"crossref","unstructured":"Zhang, X.Y., Chen, D.C., Xiu, M.H., Luo, X., Zuo, L., Haile, C.N., Kosten, T.A., and Kosten, T.R. (2012). BDNF Val66Met variant and smoking in a Chinese population. PLoS One 7: e53295, https:\/\/doi.org\/10.1371\/journal.pone.0053295.","DOI":"10.1371\/journal.pone.0053295"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_140","doi-asserted-by":"crossref","unstructured":"Zhang, H., Ozbay, F., Lappalainen, J., Kranzler, H.R., van Dyck, C.H., Charney, D.S., Price, L.H., Southwick, S., Yang, B.Z., Rasmussen, A., et al. (2006). Brain derived neurotrophic factor (BDNF) gene variants and alzheimer\u2019s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J.\u00a0Med. Genet. B Neuropsychiatr. Genet. 141B: 387\u2013393, https:\/\/doi.org\/10.1002\/ajmg.b.30332.","DOI":"10.1002\/ajmg.b.30332"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_141","doi-asserted-by":"crossref","unstructured":"Zhou, H., Kember, R.L., Deak, J.D., Xu, H., Toikumo, S., Yuan, K., Lind, P.A., Farajzadeh, L., Wang, L., Hatoum, A.S., et al. (2023). Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. Nat. Med. 29: 3184\u20133192, https:\/\/doi.org\/10.1038\/s41591-023-02653-5.","DOI":"10.1038\/s41591-023-02653-5"},{"key":"2026050312091653804_j_revneuro-2025-0112_ref_142","doi-asserted-by":"crossref","unstructured":"Zhou, H., Sealock, J.M., Sanchez-Roige, S., Clarke, T.K., Levey, D.F., Cheng, Z., Li, B., Polimanti, R., Kember, R.L., Smith, R.V., et al. (2020). Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nat. Neurosci. 23: 809\u2013818, https:\/\/doi.org\/10.1038\/s41593-020-0643-5.","DOI":"10.1038\/s41593-020-0643-5"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0112\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:55:51Z","timestamp":1777841751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0112\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":142,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,9]]},"published-print":{"date-parts":[[2026,2,24]]}},"alternative-id":["10.1515\/revneuro-2025-0112"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2025-0112","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}